Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 89 - 96 of 12008 results
Trump Signs Most-Favored-Nation Executive Order - Potential Impact on Drug Supply Chain
May 14, 2025| Blog| Viewpoint
Twenty States Sue the Trump Administration for HHS Program Eliminations and Staff Layoffs
May 14, 2025| Blog| Viewpoint
Former US Attorney for Maryland Joins Am Law 100 Firm
May 13, 2025| News
Fed. Circ. Won't Revive Sydnexis Eye Drop Patents
May 12, 2025| News
Technical CCPA Violations Result in $345,178 Fine from California Privacy Protection Agency
May 12, 2025| Blog| Viewpoint
Appeals Court Rejects AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program
May 12, 2025| Blog| Viewpoint
Ex-Maryland US Atty Joins Mintz as Crisis Management Head
May 12, 2025| News
Erek Barron, Former US Attorney for Maryland, Joins DC Law Firm
May 12, 2025| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|